Supply Chain Risk Factors and Corporate Repute in Pharma Industry of Thailand

Abstract

Chonmapat Torasa, Witthaya Mekhum.

Dealing with the risk factors has got much attention specifically in the health and pharmaceutical industry. However, due to complex nature, several risk both financial and non-financial in nature are associated with the title of supply chain in pharmaceutical industry. The purpose of this research is to analyze the various risk factors which are linked with the supply chain in the pharma sector of Thailand to predict the trends in corporate repute. For this purpose, supply side risk factors, demand side risk factors, financial risk factors, and operational risk factors were selected from the existing literature of supply chain. Besides, reputational trends through five sub items were observed through set of these risk factors. To examine the relationship between the variables, a questionnaire was developed for the data collection in the economy of Thailand with a sample of 169 respondents. The results show that supply chain risk factors like lack of information sharing, lack of captain category supplier, interest rate risk, exchange rate risk, machine or equipment failure, quality risk are significantly and adversely impacting on the different dimensions of corporate repute in pharma sector of Thailand. Besides, detailed review of the literature has demonstrated that this research is among the initial contribution for discussing the relationship between supply chain risk factors and their influence on the corporate repute in pharmaceutical sector of Thailand. for this reason, various stakeholders would get the benefit from the study findings in compiling the future studies on the similar topic. However, research limitations like expanding the sample size, considering cross country analysis, and implication of structural modelling approaches may provide some interesting and different results in coming time.

How to Cite this Article
Pubmed Style

Chonmapat Torasa, Witthaya Mekhum. Supply Chain Risk Factors and Corporate Repute in Pharma Industry of Thailand. SRP. 2020; 11(4): 94-101. 
doi:10.31838/srp.2020.4.16

Web Style

Chonmapat Torasa, Witthaya Mekhum. Supply Chain Risk Factors and Corporate Repute in Pharma Industry of Thailand. http://www.sysrevpharm.org/?mno=98607 [Access: March 30, 2021]. doi:10.31838/srp.2020.4.16

AMA (American Medical Association) Style

Chonmapat Torasa, Witthaya Mekhum. Supply Chain Risk Factors and Corporate Repute in Pharma Industry of Thailand. SRP. 2020; 11(4): 94-101. doi:10.31838/srp.2020.4.16



Vancouver/ICMJE Style

Chonmapat Torasa, Witthaya Mekhum. Supply Chain Risk Factors and Corporate Repute in Pharma Industry of Thailand. SRP. (2020), [cited March 30, 2021]; 11(4): 94-101. doi:10.31838/srp.2020.4.16



Harvard Style

Chonmapat Torasa, Witthaya Mekhum (2020) Supply Chain Risk Factors and Corporate Repute in Pharma Industry of Thailand. SRP, 11 (4), 94-101. doi:10.31838/srp.2020.4.16



Turabian Style

Chonmapat Torasa, Witthaya Mekhum. 2020. Supply Chain Risk Factors and Corporate Repute in Pharma Industry of Thailand. Systematic Reviews in Pharmacy, 11 (4), 94-101. doi:10.31838/srp.2020.4.16



Chicago Style

Chonmapat Torasa, Witthaya Mekhum. "Supply Chain Risk Factors and Corporate Repute in Pharma Industry of Thailand." Systematic Reviews in Pharmacy 11 (2020), 94-101. doi:10.31838/srp.2020.4.16



MLA (The Modern Language Association) Style

Chonmapat Torasa, Witthaya Mekhum. "Supply Chain Risk Factors and Corporate Repute in Pharma Industry of Thailand." Systematic Reviews in Pharmacy 11.4 (2020), 94-101. Print. doi:10.31838/srp.2020.4.16



APA (American Psychological Association) Style

Chonmapat Torasa, Witthaya Mekhum (2020) Supply Chain Risk Factors and Corporate Repute in Pharma Industry of Thailand. Systematic Reviews in Pharmacy, 11 (4), 94-101. doi:10.31838/srp.2020.4.16

Most Viewed Articles
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli SRP. 2020; 11(1): 01-06 » doi: 10.5530/srp.2020.1.01
  • Psychometric properties of the World Health Organization Quality of life instrument, short form: Validity in the Vietnamese healthcare context Trung Quang Vo*, Bao Tran Thuy Tran, Ngan Thuy Nguyen, Tram ThiHuyen Nguyen, Thuy Phan Chung Tran SRP. 2020; 11(1): 14-22 » doi: 10.5530/srp.2019.1.3
  • A Review of Pharmacoeconomics: the key to “Healthcare for All” Hasamnis AA, Patil SS, Shaik Imam, Narendiran K SRP. 2019; 10(1): s40-s42 » doi: 10.5530/srp.2019.1s.21
  • Deuterium Depleted Water as an Adjuvant in Treatment of Cancer Anton Syroeshkin, Olga Levitskaya, Elena Uspenskaya, Tatiana Pleteneva, Daria Romaykina, Daria Ermakova SRP. 2019; 10(1): 112-117 » doi: 10.5530/srp.2019.1.19
Most Downloaded
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli SRP. 2020; 11(1): 01-06 » doi: 10.5530/srp.2020.1.01
  • Manilkara zapota (L.) Royen Fruit Peel: A Phytochemical and Pharmacological Review Karle Pravin P, Dhawale Shashikant C SRP. 2019; 10(1): 11-14 » doi: 0.5530/srp.2019.1.2
  • Pharmacognostic and Phytopharmacological Overview on Bombax ceiba Pankaj Haribhau Chaudhary, Mukund Ganeshrao Tawar SRP. 2019; 10(1): 20-25 » doi: 10.5530/srp.2019.1.4
  • A Review of Pharmacoeconomics: the key to “Healthcare for All” Hasamnis AA, Patil SS, Shaik Imam, Narendiran K SRP. 2019; 10(1): s40-s42 » doi: 10.5530/srp.2019.1s.21
  • A Prospective Review on Phyto-Pharmacological Aspects of Andrographis paniculata Govindraj Akilandeswari, Arumugam Vijaya Anand, Palanisamy Sampathkumar, Puthamohan Vinayaga Moorthi, Basavaraju Preethi SRP. 2019; 10(1): 15-19 » doi: 10.5530/srp.2019.1.3